{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:21:10Z","timestamp":1767651670742},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.diabres.2018.01.009","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T07:17:57Z","timestamp":1517555877000},"page":"221-223","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Targeting testosterone measurements to patients with type 2 diabetes mellitus and moderate to severe symptomatic erectile dysfunction"],"prefix":"10.1016","volume":"137","author":[{"given":"Raman","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jubbin J.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2018.01.009_b0005","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc06-1426","article-title":"Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity","volume":"30","author":"Kapoor","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.01.009_b0010","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/jc.2010-2724","article-title":"Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity","volume":"96","author":"Dandona","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2018.01.009_b0015","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.2337\/dc11-0208","article-title":"Low estradiol concentrations in males with subnormal testosterone concentrations and type 2 diabetes","volume":"34","author":"Dhindsa","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.01.009_b0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4137\/CMED.S27700","article-title":"Androgen deficiency and erectile dysfunction in patients with type 2 diabetes","volume":"8","author":"El Saghier","year":"2015","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"10.1016\/j.diabres.2018.01.009_b0025","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Task force, endocrine society. testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2018.01.009_b0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diabres.2018.01.009_b0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4103\/0253-7176.140727","article-title":"Validation of sexual functioning questionnaire in indian patients","volume":"36","author":"Krishna","year":"2014","journal-title":"Ind J Psychol Med"},{"key":"10.1016\/j.diabres.2018.01.009_b0040","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1210\/jc.2007-2177","article-title":"Low testosterone levels are common and associated with insulin resistance in men with diabetes","volume":"93","author":"Grossmann","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2018.01.009_b0045","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc06-1426","article-title":"Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes","volume":"30","author":"Kapoor","year":"2007","journal-title":"Diabetic Care"},{"key":"10.1016\/j.diabres.2018.01.009_b0050","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.metabol.2003.12.016","article-title":"Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control","volume":"53","author":"Corrales","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2018.01.009_b0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4158\/EP09035.ORR","article-title":"Prevalence of hypogonadism in patients with type 2 diabetes mellitus in an Asian Indian study group","volume":"15","author":"Ganesh","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/j.diabres.2018.01.009_b0060","doi-asserted-by":"crossref","unstructured":"Hackett G, Cole N, Saghir A, Jones P, Strange RC, Ramachandran S. Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study. BJU International; 2016. (Online only) http:\/\/doi.org\/10.1111\/bju.13516.","DOI":"10.1111\/bju.13516"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717319253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717319253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T21:18:14Z","timestamp":1530825494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822717319253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":12,"alternative-id":["S0168822717319253"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2018.01.009","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting testosterone measurements to patients with type 2 diabetes mellitus and moderate to severe symptomatic erectile dysfunction","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2018.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}